Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 2;14(12):1785.
doi: 10.1093/ecco-jcc/jjaa102.

Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing?

Fabiana Zingone  1 , Andrea Buda  2 , Edoardo Vincenzo Savarino  1
Affiliations
Comment

Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing?

Fabiana Zingone et al. J Crohns Colitis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Monteleone G, Ardizzone S. Are patients with inflammatory bowel disease at increased risk for COVID-19 infection? J Crohns Colitis 2020, Mar 26. doi: 10.1093/ecco-jcc/jjaa061. [Epub ahead of print.] - PMC - PubMed
    1. Surveillance Epidemiology of Coronavirus Under Research Exclusion [SECURE-IBD]. https://covidibd.org/. Accessed April 3, 2020.
    1. Bezzio C, Saibeni S, Variola A, et al. . Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut 2020. doi: 10.1136/gutjnl-2020-321411. - DOI - PubMed
    1. Singh S, Facciorusso A, Dulai PS, et al. . Comparative risk of serious infections with biologic and/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2020;18:69–81.e3 - PMC - PubMed
    1. Zingone F, Buda A, Savarino EV. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Dig Liver Dis 2020. doi: 10.1016/j.dld.2020.04.004. - DOI - PMC - PubMed